[사회]’Russian vaccine introduction review’ … ‘break’ vaccine supply and demand plan

[앵커]

Quarantine authorities said they are also considering introducing the COVID-19 vaccine from Russia.

Just four days ago, he said he was not negotiating a contract, but the ‘intro’ talk came out.

As such, it can be read as a rebuttal that the government’s vaccine supply plan is uncertain.

Reporter Park Hong-gu about the report.

[기자]

On day 4, when asked if Russia’s Sputnik V vaccine was introduced, the KCDC replied:

[양동교 / 질병관리청 의료안전예방국장 : 현재 스푸트니크에 대해서는 협상을 또는 논의를 진행하고 있지 않다는 말씀을 드리겠습니다.]

Just four days later, Sputnik said that this time, all vaccines would be candidates for review.

[정은경 / 질병관리청장 : 워낙 불확실성이 많기 때문에 다양한 백신들을 다 문을 열어놓고 가능성에 대해서 검토하겠다는 그런 답변으로 이해해주시면 되겠습니다.]

Experts also believe that the results of the Sputnik V phase 3 clinical trial, which showed more than 91% immunological effect, were published in the international medical journal ‘Lancet’ as a significant result.

[백순영 / 가톨릭의대 명예교수 : 랜싯의 리뷰를 받았다는 얘기는 거기의 연구자들이 다 살펴보고 이건 틀림없다는 것을 확인해 준 것이거든요.]

The government’s interest in Russian vaccines runs counter to the uncertainty of its plans to introduce a vaccine for 56 million people.

In particular, there is no guarantee that Kobax’s 10 million installs will be introduced in the first quarter.

[정은경 / 질병관리청장 : 행정적인 절차에 따라서 조금 공급 일정은 조정이 될 여지가 있습니다. 저희가 통제하기 어려운 그런 절차들이 있는 상황이고요.]

However, the amount that AstraZeneca and NovaVax will introduce is reassuring, as it is possible to produce shipments in Korea.

Still, the introduction of Modena 20 million and Pfizer 10 million may be uncertain in the second and third quarters, respectively, due to the spread of the mutant virus around the world and the consequent increase in demand for vaccines.

This is YTN Park Hong-gu.

※ ‘Your report becomes news’ YTN is waiting for your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]